Medical Cannabis for Schizophrenia in Canada

Living with schizophrenia presents unique challenges that impact nearly every aspect of daily life, from social relationships to work performance to overall well being. As a complex neuropsychiatric condition, schizophrenia affects how a person thinks, feels, and behaves, often making it difficult to distinguish between what is real and what is not.

While conventional treatments for schizophrenia typically focus on antipsychotic medications and therapy, there’s growing interest in exploring complementary approaches that might help manage specific symptoms or side effects. There’s some interest in using cannabis to treat symptoms of bipolar disorder and/or schizophrenia, though this area requires careful consideration and medical supervision.

It’s important to note that the relationship between cannabis and schizophrenia is complex. Research suggests that for some individuals, particularly those with a genetic predisposition, recreational cannabis use may be associated with an increased risk of psychosis. However, specific cannabinoids under medical supervision might have different effects than recreational use, and some preliminary research suggests potential benefits for certain symptoms.

Schizophrenia is a primary psychotic disorder, and bipolar disorder is a primary mood disorder, but can also involve psychosis. Differentiating between the two can sometimes be difficult because of some similar symptoms.

What is Schizophrenia?

Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may seem like they have lost touch with reality, which causes significant distress for the individual, their family members, and friends.

The condition typically emerges in late adolescence or early adulthood, with onset usually occurring between the ages of 16-30. It affects approximately 1% of the population worldwide and is considered one of the most debilitating psychiatric conditions.

Common Symptoms of Schizophrenia

Symptoms of schizophrenia are often categorized into three main types:

Positive Symptoms (Psychotic Symptoms)

These are thoughts, perceptions, and behaviours that are not normally present:

•  Hallucinations (hearing, seeing, or feeling things that aren’t there)
•  Delusions (false beliefs not based in reality)
•  Disorganized thinking and speech
•  Abnormal motor behaviour (agitated movements or inappropriate posture)

Negative Symptoms

These represent a reduction or loss of normal functions:

•  Lack of pleasure in everyday activities
•  Reduced emotional expression (“flat affect”)
•  Reduced speaking
•  Difficulty beginning and sustaining activities
•  Social withdrawal

Cognitive Symptoms

These involve problems with attention and mental tasks:

•  Difficulty making decisions
•  Problems with “working memory” (ability to use information immediately after learning it)
•  Trouble focusing or paying attention
•  Problems with “executive functioning” (ability to understand information and use it for decision-making)

The overlap between some of these symptoms and those found in bipolar disorder can sometimes make diagnosis challenging. For instance, jumping from one idea to another and being unusually distracted during a manic episode may resemble “disorganized thinking,” characteristic of schizophrenia.

Impact on Daily Life

Schizophrenia can significantly impact various aspects of a person’s life:

Social Functioning

•  Difficulty maintaining relationships
•  Social isolation
•  Problems with communication
•  Loss of social skills

Occupational Functioning

•  Challenges in finding or maintaining employment
•  Reduced productivity
•  Difficulties with workplace interactions

Independent Living

•  Struggles with self-care
•  Difficulty managing daily tasks
•  Housing instability
•  Financial challenges

Physical Health

•  Higher rates of metabolic disorders (often related to medication)
•  Increased risk of cardiovascular disease
•  Higher rates of substance use disorders
•  Shorter life expectancy compared to the general population

Risk Factors for Schizophrenia

Several factors may contribute to the development of schizophrenia:

•  Genetics: Having a family history of schizophrenia increases risk
•  Environmental factors: Pregnancy and birth complications, childhood trauma
•  Brain chemistry: Imbalances in neurotransmitters like dopamine and glutamate
•  Substance use: Heavy cannabis use during adolescence may increase risk in vulnerable individuals

The relationship between cannabis and schizophrenia is multifaceted and requires careful consideration:

Recreational Cannabis Use and Psychosis Risk

Research indicates that recreational cannabis use, particularly high-THC varieties during adolescence, may be associated with an increased risk of developing psychosis in vulnerable individuals. Factors that may influence this risk include:

•  Genetic predisposition
•  Age of first use
•  Frequency and duration of use
•  Potency (THC content) of cannabis used
•  Presence of other risk factors

This relationship is complex and does not affect all users, but it’s an important consideration when discussing cannabis in the context of schizophrenia.

Potential Therapeutic Applications Under Investigation

Despite the risks associated with recreational use, specific cannabinoids under medical supervision are being investigated for potential therapeutic benefits:

CBD (Cannabidiol)

•  Non-intoxicating component of cannabis
•  May have antipsychotic properties
•  Early research suggests potential for reducing psychotic symptoms
•  May have fewer side effects than traditional antipsychotics
•  Could potentially help with anxiety often co-occurring with schizophrenia

Balanced CBD:THC Ratios

•  May help address specific symptoms in some patients
•  Could potentially reduce antipsychotic medication side effects
•  Might improve treatment adherence in select cases

It’s crucial to note that research in this area is still preliminary, and any consideration of cannabis use in schizophrenia must be approached with caution and under close medical supervision.

For individuals with schizophrenia, medical cannabis presents both potential benefits and significant risks that must be carefully weighed:

Potential Benefits Under Investigation

Studies are exploring whether carefully monitored medical cannabis, particularly CBD-dominant formulations, might offer certain benefits:

•  Reduction in anxiety and stress
•  Improvement in sleep quality
•  Potential antipsychotic properties of CBD
•  Possible reduction in antipsychotic medication side effects
•  Management of comorbid conditions like depression

Significant Risks and Concerns

•  Potential exacerbation of psychotic symptoms, particularly with THC
•  Possible interference with antipsychotic medications
•  Risk of developing cannabis use disorder
•  Cognitive impacts that could worsen existing cognitive symptoms
•  Social and functional impacts

Any consideration of medical cannabis for schizophrenia must involve a comprehensive risk-benefit analysis performed by healthcare providers with expertise in both schizophrenia and cannabinoid medicine.

If medical cannabis is being considered as part of a schizophrenia treatment plan, several important principles should guide this approach:

Cautious, Evidence-Informed Approach

•  Start with CBD-dominant or CBD-only products
•  Extremely low doses with very gradual adjustments
•  Regular monitoring of symptoms and side effects
•  Clear exit strategy if symptoms worsen

Integration with Conventional Treatment

•  Continuation of prescribed antipsychotic medications
•  Regular communication with the psychiatric care team
•  Combined approach with psychosocial interventions
•  Focus on comprehensive care rather than replacement therapy

Individualized Assessment

•  Careful evaluation of personal and family history
•  Consideration of previous responses to cannabis
•  Monitoring for specific symptom changes
•  Ongoing reassessment of risk-benefit balance

Focus on Harm Reduction

•  Education about potential risks
•  Clear guidelines for use
•  Regular check-ins and monitoring
•  Support for substance use concerns if they arise

If you’re considering discussing medical cannabis as a complementary approach to schizophrenia treatment, here’s how to begin the process:

1. Prepare for your consultation

Before booking an appointment:

• Gather your medical records, including psychiatric history
• Make a list of all current medications and treatments
• Document your symptoms and treatment goals
• Consider bringing a trusted support person
• Obtain a referral from your psychiatrist if possible

2. Book an online consultation

Our streamlined process makes it easy:

• Schedule a video consultation with a healthcare provider
• Complete a comprehensive questionnaire about your psychiatric history
• Be prepared to discuss your current treatment plan
• Consider having your psychiatrist or case manager join the consultation

3. Collaborative decision-making

During your consultation:

• The healthcare provider will conduct a thorough assessment
• They will discuss potential benefits and risks specific to your situation
• If appropriate, they will develop a cautious treatment plan
• In many cases, they may recommend maintaining your current treatment without adding cannabis

4. Ongoing monitoring and support

If a trial of medical cannabis is recommended:

• Regular follow-up consultations to monitor for symptom changes
• Coordination with your psychiatric care team
• Careful tracking of effects on symptoms and functioning
• Immediate access to support if concerns arise

Our approach to schizophrenia is characterized by extreme caution, evidence-based decision-making, and close coordination with your existing mental health providers. In many cases, we may determine that medical cannabis is not appropriate, and we will honestly communicate this recommendation.

If you have schizophrenia or a related condition, several important considerations should guide any discussion about cannabis:

Medication Interactions

•  Cannabis may affect blood levels of certain antipsychotics
•  This could potentially reduce medication effectiveness
•  Close monitoring of medication levels may be necessary
•  Never adjust your psychiatric medications without medical supervision

Symptom Monitoring

•  Be vigilant for any changes in hallucinations or delusions
•  Monitor for increased paranoia or disorganized thinking
•  Track sleep patterns and energy levels
•  Be aware of social functioning and motivation

Substance Use Concerns

•  People with schizophrenia have higher rates of substance use disorders
•  Cannabis use disorder is a potential risk
•  Regular assessment for problematic use patterns
•  Support resources should be readily available

Support System Involvement

•  Involve trusted family members or friends in the decision
•  Ensure someone can help monitor for concerning changes
•  Have clear communication channels with healthcare providers
•  Establish an emergency plan if symptoms worsen